questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines du cytosquelette
Protéines de filaments intermédiaires
Protéines de filaments intermédiaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Général
1
Intermediate Filament Proteins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de filaments intermédiaires : Questions médicales les plus fréquentes",
"headline": "Protéines de filaments intermédiaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de filaments intermédiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de filaments intermédiaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines du cytosquelette",
"url": "https://questionsmedicales.fr/mesh/D003598",
"about": {
"@type": "MedicalCondition",
"name": "Protéines du cytosquelette",
"code": {
"@type": "MedicalCode",
"code": "D003598",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Desmine",
"alternateName": "Desmin",
"url": "https://questionsmedicales.fr/mesh/D003893",
"about": {
"@type": "MedicalCondition",
"name": "Desmine",
"code": {
"@type": "MedicalCode",
"code": "D003893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine gliofibrillaire acide",
"alternateName": "Glial Fibrillary Acidic Protein",
"url": "https://questionsmedicales.fr/mesh/D005904",
"about": {
"@type": "MedicalCondition",
"name": "Protéine gliofibrillaire acide",
"code": {
"@type": "MedicalCode",
"code": "D005904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kératine-15",
"alternateName": "Keratin-15",
"url": "https://questionsmedicales.fr/mesh/D053569",
"about": {
"@type": "MedicalCondition",
"name": "Kératine-15",
"code": {
"@type": "MedicalCode",
"code": "D053569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.450.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vimentine",
"alternateName": "Vimentin",
"url": "https://questionsmedicales.fr/mesh/D014746",
"about": {
"@type": "MedicalCondition",
"name": "Vimentine",
"code": {
"@type": "MedicalCode",
"code": "D014746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de filaments intermédiaires",
"alternateName": "Intermediate Filament Proteins",
"code": {
"@type": "MedicalCode",
"code": "D007381",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sarah Köster",
"url": "https://questionsmedicales.fr/author/Sarah%20K%C3%B6ster",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Sandrine Etienne-Manneville",
"url": "https://questionsmedicales.fr/author/Sandrine%20Etienne-Manneville",
"affiliation": {
"@type": "Organization",
"name": "Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Charlotta Lorenz",
"url": "https://questionsmedicales.fr/author/Charlotta%20Lorenz",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Anna V Schepers",
"url": "https://questionsmedicales.fr/author/Anna%20V%20Schepers",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Rudolf E Leube",
"url": "https://questionsmedicales.fr/author/Rudolf%20E%20Leube",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Repurposing Drugs: An Empowering Approach to Drug Discovery and Development.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37478892",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2095-0826"
}
},
{
"@type": "ScholarlyArticle",
"name": "Drug Combination Modeling: Methods and Applications in Drug Development.",
"datePublished": "2022-09-11",
"url": "https://questionsmedicales.fr/article/36088583",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcph.2128"
}
},
{
"@type": "ScholarlyArticle",
"name": "Challenges and opportunities in NASH drug development.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36894650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41591-023-02242-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enzymes as Targets for Drug Development II.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36834666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24043258"
}
},
{
"@type": "ScholarlyArticle",
"name": "Costs of Drug Development and Research and Development Intensity in the US, 2000-2018.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38941099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.15445"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines du cytosquelette",
"item": "https://questionsmedicales.fr/mesh/D003598"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de filaments intermédiaires",
"item": "https://questionsmedicales.fr/mesh/D007381"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de filaments intermédiaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de filaments intermédiaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Général",
"headline": "Général sur Protéines de filaments intermédiaires",
"description": "Erreur lors de la génération.",
"url": "https://questionsmedicales.fr/mesh/D007381?mesh_terms=Drug+Development#section-général"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Erreur lors de la génération.",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Veuillez réessayer ultérieurement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/02/2025
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
8 publications dans cette catégorie
Affiliations :
Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr.
6 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
5 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
4 publications dans cette catégorie
Affiliations :
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, D-13125 Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, D-10785 Berlin, Germany.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: coulombe@umich.edu.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Mathematics, University of Manitoba, Winnipeg, MB, Canada.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuropathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Institute for Dynamics of Complex Systems, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia. alexminin@gmail.com.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Histology and Embryology, Faculty of Veterinary Medicine, Dicle University, Diyarbakır, Turkey.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Mathematics, Brigham Young University, 344 TMCB, Provo, Utah 84602-6539, USA. Electronic address: dallon@math.byu.edu.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institut Pasteur Paris CNRS UMR3691, Cell Polarity, Migration and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, 25 rue du Dr Roux, Paris Cedex 15, 75724, France.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, 20520 Turku, Finland.
Euro-Bioimaging ERIC, 20520 Turku, Finland.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Celica BIOMEDICAL, 1000 Ljubljana, Slovenia.
Department of Biochemistry and Cell Biology, Max F. Perutz Laboratories, University of Vienna, 1030 Vienna, Austria.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :
Drug discovery and development is a time-consuming and costly procedure that necessitates a substantial effort. Drug repurposing has been suggested as a method for developing medicines that takes less...
Combination therapies have become increasingly researched and used in the treatment and management of complex diseases due to their ability to increase the chances for better efficacy and decreased to...
Nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), represent a growing worldwide epidemic and a high unmet medical need, as no licensed drugs have ...
Enzymes are viewed as the most desirable targets for drug development by the pharmaceutical community [...]....
Understanding the cost of drug development can help inform the development of policies to reduce costs, encourage innovation, and improve patient access to drugs....
To estimate the cost of drug development by therapeutic class and trends in pharmaceutical research and development (R&D) intensity over time....
In this economic evaluation study, an analytical model of drug development constructed using public and proprietary sources that collectively cover data from 2000 to 2018 was used to estimate the cost...
Three measures of development cost from nonclinical through postmarketing stages were estimated: mean out-of-pocket cost or cash outlay, mean expected cost, and mean expected capitalized cost. Pharmac...
The estimated mean cost of developing a new drug was approximately $172.7 million (2018 dollars) (range, $72.5 million for genitourinary to $297.2 million for pain and anesthesia), inclusive of postma...
In this economic evaluation of new drug development costs, even though the cost of drug development appears to have remained stable, R&D intensity of large pharmaceutical companies remained relatively...
As part of a collaboration between Medicines for Malaria Venture (MMV), Certara UK and Monash University, physiologically-based pharmacokinetic (PBPK) models were developed for 20 antimalarials, using...
The birth of ChatGPT, a cutting-edge language model-based chatbot developed by OpenAI, ushered in a new era in AI. However, due to potential pitfalls, its role in rigorous scientific research is not c...
Significant evidences indicate that sub-cellular organelle dynamics is critical for both physiological and pathological events and therefore may be attractive drug targets displaying great therapeutic...
The incidence of allergic disease significantly increases in recent decades, causing it become a major public health problem all over the world. The common allergic diseases such as allergic dermatiti...
Master protocols are innovative clinical trial designs that enable new approaches to analytics and operations, creating value for patients and drug developers. To date, the use of master protocols in ...